Successful immunization with a totally synthetic diphtheria vaccine - Wikidata - wikimedia - TriplyDB

Successful immunization with a totally synthetic diphtheria vaccine

Successful immunization with a totally synthetic diphtheria vaccine

http://www.wikidata.org/entity/Q36308543

about

Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2 A 20-kilodalton N-terminal fragment of the D15 protein contains a protective epitope(s) against Haemophilus influenzae type a and type b.Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein.Human antibody response to fragments A and B of diphtheria toxin and a synthetic peptide of amino acid residues 141-157 of fragment A Peptide component vaccine engineering: targeting the AIDS virus.HLA-DR: molecular insights and vaccine design.Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivative Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides.Site-specific antibodies to human erythropoietin directed toward the NH2-terminal region.Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.Current trends and advances in bacterial vaccines today.Depressed chemiluminescence response by influenza virus is enhanced after conjugation of viral subunits to muramyl dipeptide.MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants.Solution conformation of an immunogenic peptide from HRV2: comparison with the conformation found in a complex with a Fab fragment of an anti-HRV2 neutralizing antibody.Synthetic Antigens and Vaccines

P2860

Q27731338-2ADE0BEF-DE5B-4696-841C-7C5A94EB5411 Q33756634-C043E0DA-9CD7-4316-8423-B871241C712E Q36267209-A8787590-4445-4A7D-A730-81C59794DED6 Q36505082-4BA9F928-78D1-4EFF-A0BD-953802D30C00 Q36708999-D23E872B-1E6E-4756-A6D6-C63B426CC587 Q36737531-1EFD80BE-2933-4EBD-B921-F6B7F62A24BE Q37007738-19485C9C-761D-4FAA-A102-0FCBA708F006 Q37020185-9E3E1407-B168-450E-BB8F-C1CBD55F3DDC Q37034348-5CB24733-6A77-4A41-B997-3570BFB6D050 Q37049985-DADCFC2D-3B6D-496C-80CC-F07251FE9041 Q37077896-EBFCD710-E291-48E6-802E-CB639A4D35E2 Q37580591-4E6EE153-3F0C-4435-B58A-46C907E7792A Q37614895-9DF4A575-4C93-4A77-9FA8-5A865F2F6868 Q37690884-EEEEBB09-946F-4990-83F8-D1402F7FF2E1 Q39764904-A7AFA050-2770-4931-B05D-156253F08683 Q40171239-EB5ACE37-56E2-4899-9C9D-BF18CBB537A8 Q41983452-7EA70704-956F-45D7-9438-7631A78D7F70 Q42939044-32AE48ED-3FE1-4297-907A-1BB525CCFAAC Q47992601-52307280-C50B-49B4-958D-F36C2BEBA161 Q58352976-FA183AAD-C331-4CEB-B1BC-E87A79F47F52

P2860

Successful immunization with a totally synthetic diphtheria vaccine

http://www.wikidata.org/entity/Q36308543

description

1982 nî lūn-bûn

@nan

1982年の論文

@ja

1982年学术文章

@wuu

1982年学术文章

@zh-cn

1982年学术文章

@zh-hans

1982年学术文章

@zh-my

1982年学术文章

@zh-sg

1982年學術文章

@yue

1982年學術文章

@zh

1982年學術文章

@zh-hant

name

Successful immunization with a totally synthetic diphtheria vaccine

@ast

Successful immunization with a totally synthetic diphtheria vaccine

@en

type

label

Successful immunization with a totally synthetic diphtheria vaccine

@ast

Successful immunization with a totally synthetic diphtheria vaccine

@en

prefLabel

Successful immunization with a totally synthetic diphtheria vaccine

@ast

Successful immunization with a totally synthetic diphtheria vaccine

@en

P1433

Q36308543-C4FE6B67-061D-40BA-9B23-24DF04DD6805

P1476

Q36308543-24B90F98-BBE5-4C38-A28D-726BBF70C136

P2093

Q36308543-05DB96A4-01F8-41A7-B8EA-235424474933

Q36308543-79908826-2C19-44C6-BEE4-183532039D10

Q36308543-BAA07FF4-570C-4538-A8A8-A7A513C22CAD

Q36308543-D0D1D9E7-2DF6-420E-ADFE-AF51193D6F92

Q36308543-E0532CB7-38F6-4199-AE03-5C1D5EAB6F09

P2860

Q36308543-06059B86-8D1C-40FB-9530-1CED411A41FA

Q36308543-1DD27B44-C010-47A9-A89E-9E3E8DE45160

Q36308543-1E02B375-719E-486A-A6DC-450792A66931

Q36308543-22E0E8F9-25FF-4919-8417-31B2EDAF13D4

Q36308543-278351A2-B2B3-48AB-B5A1-1EFF1BF2436F

Q36308543-2F177746-596F-4D78-86EB-3B3BF86F7330

Q36308543-449DD66C-4678-4292-AD84-DAE8C9D174A3

Q36308543-44F16727-28F6-40FA-9D4F-62D4B6EA17B7

Q36308543-4AC5367F-27FC-45A7-B121-D7DD0826E256

Q36308543-51B5604A-68DD-4DA8-A7ED-8CFB5197A28C

P304

Q36308543-D956A20D-4051-47E3-B0FD-BDA3CB6279F4

P31

Q36308543-0E75FC22-37C0-4A37-ABE6-5B55F929C02D

P356

Q36308543-F6528B76-A997-4AA2-BB6F-258C32CC0B54

P407

Q36308543-7E10E8DA-85BC-4CD7-B0E3-E3D0F2D696C3

P433

Q36308543-00DCA14C-3D99-40F0-BD27-E955A2C03CCD

P478

Q36308543-A6A90433-A93A-49E5-9EAD-38C9A5653176

P577

Q36308543-7D3A81FD-0754-411B-8E05-94410F317F96

P5875

Q36308543-42C02CA5-51D3-4A83-AA92-96CF89EBE9DD

P698

Q36308543-3073DB99-871B-4306-8D90-4AC358328FDD

P921

Q36308543-4BD10EAD-B0F8-4483-B9B6-A2325CE74AAB

P932

Q36308543-85735AA9-BDA0-4A10-AF98-05760975EE1F

P356

PNAS.79.16.5042

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Successful immunization with a totally synthetic diphtheria vaccine

@en

P2093

Arnon R

http://www.w3.org/2001/XMLSchema#string

Audibert F

http://www.w3.org/2001/XMLSchema#string

Chedid L

http://www.w3.org/2001/XMLSchema#string

Jolivet M

http://www.w3.org/2001/XMLSchema#string

Sela M

http://www.w3.org/2001/XMLSchema#string

P2860

Diphtheria toxin

Diphtheria toxin: mode of action and structure

Prediction of protein antigenic determinants from amino acid sequences

Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.

Immunogenic properties of soluble antigens or whole cells of Brucella abortus strain 45/20 associated with immunoadjuvants. I. Soluble antigens

Immunogenic properties of soluble antigens or whole cells of Brucella abortus strain 45/20 associated with immunoadjuvants. II. Whole cells.

Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.

Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.

Anti-influenza response achieved by immunization with a synthetic conjugate.

Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.

P304

5042-5046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.79.16.5042

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

1982-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16241947

http://www.w3.org/2001/XMLSchema#string

P698

6956913

http://www.w3.org/2001/XMLSchema#string

P921

P932

346823

http://www.w3.org/2001/XMLSchema#string